Oprah Winfrey Shows Slimmer Appearance, Says She Uses Doctor-Prescribed GLP-1 Medication to Prevent Yo-Yo Weighting

Oprah Winfrey, 71, appeared visibly slimmer in a recent Instagram post and has said she uses a doctor-prescribed GLP-1 medication as a tool to avoid recurring weight fluctuations, a change she made public after years of scrutiny over her weight.

Winfrey shared a self-portrait on Instagram to promote her book club, showing a noticeably slimmer physique while holding a copy of Elizabeth Gilbert’s memoir All the Way to the River. She disabled comments on the post amid public discussion about her use of a weight loss medication; she has not publicly disclosed the specific drug by name.

Winfrey has discussed her weight history in public forums for decades. She has said her highest weight was 237 pounds and has described a lifetime of dieting and weight cycling. She told People and attendees at a July 2023 recorded panel, part of Oprah Daily’s The Life You Want series, that the discussion with medical experts on obesity and weight loss helped her overcome reluctance to use the medication. "I now use it as I feel I need it — as a tool to avoid yo-yoing," she said.

Medical regulators have approved several drugs in the glucagon-like peptide-1 (GLP-1) class to treat type 2 diabetes; some of those drugs, when prescribed off-label or in formulations approved for weight management, have been shown to produce weight loss. Media coverage and public discussion have frequently linked high-profile weight changes to GLP-1 medications such as semaglutide, marketed under brand names including Ozempic and Wegovy, though Winfrey has not confirmed using a specific brand.

Winfrey has previously endorsed and invested in weight-management programs. In 2015 she disclosed a roughly 10% stake in Weight Watchers and attributed part of a prior weight loss to the program’s points-based approach. She later stepped down from the Weight Watchers board after revealing she had begun using a doctor-prescribed GLP-1 medication.

Her public statements about medication have drawn criticism and prompted discussion about changing social attitudes toward medical weight-management therapies. At times in the past she criticized GLP-1 drugs, calling them an "easy way out," remarks that drew rebuke from some observers. More recently, she has said she was "done with the shaming," framing the availability of a medically approved prescription option as "relief, like redemption, like a gift," and has said she recommended the option to others before deciding to use it herself.

Winfrey has described the origins of her health shift as beginning after knee surgery in 2021, when she began hiking and setting distance goals. She said increased activity and a different approach to managing weight influenced her decision to take the medication to prevent further weight cycling.

The broader medical community has noted that GLP-1 medications can lead to significant weight loss for some patients but that use should be individualized and supervised by a clinician because of potential side effects and varying long-term outcomes. Public debate has centered on access, cost, the ethics of off-label prescribing, and the social stigma attached to using medications for weight management. Winfrey’s disclosure has added a high-profile example to that ongoing discussion.

In her Instagram post, Winfrey focused on her book club selection rather than medical details. She has continued to speak publicly about her experience, emphasizing management of long-term health rather than short-term results.